17135220

Source:http://linkedlifedata.com/resource/pubmed/id/17135220

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0001675, umls-concept:C0023983, umls-concept:C0030705, umls-concept:C0031842, umls-concept:C0036043, umls-concept:C0087111, umls-concept:C0152021, umls-concept:C0152171, umls-concept:C0205210, umls-concept:C0252643, umls-concept:C0439849, umls-concept:C0445223, umls-concept:C1280500, umls-concept:C1552599, umls-concept:C1704787
pubmed:issue	5
pubmed:dateCreated	2007-4-16
pubmed:abstractText	Oral bosentan is an established treatment for pulmonary arterial hypertension (PAH).
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/17135220-10402046, http://linkedlifedata.com/resource/pubmed/commentcorrection/17135220-11597664, http://linkedlifedata.com/resource/pubmed/commentcorrection/17135220-11907289, http://linkedlifedata.com/resource/pubmed/commentcorrection/17135220-12411974, http://linkedlifedata.com/resource/pubmed/commentcorrection/17135220-12709727, http://linkedlifedata.com/resource/pubmed/commentcorrection/17135220-13041990, http://linkedlifedata.com/resource/pubmed/commentcorrection/17135220-13572894, http://linkedlifedata.com/resource/pubmed/commentcorrection/17135220-14736539, http://linkedlifedata.com/resource/pubmed/commentcorrection/17135220-15246919, http://linkedlifedata.com/resource/pubmed/commentcorrection/17135220-15483284, http://linkedlifedata.com/resource/pubmed/commentcorrection/17135220-15589643, http://linkedlifedata.com/resource/pubmed/commentcorrection/17135220-15676179, http://linkedlifedata.com/resource/pubmed/commentcorrection/17135220-15684287, http://linkedlifedata.com/resource/pubmed/commentcorrection/17135220-15761050, http://linkedlifedata.com/resource/pubmed/commentcorrection/17135220-16098438, http://linkedlifedata.com/resource/pubmed/commentcorrection/17135220-16801459, http://linkedlifedata.com/resource/pubmed/commentcorrection/17135220-2054934, http://linkedlifedata.com/resource/pubmed/commentcorrection/17135220-2678869, http://linkedlifedata.com/resource/pubmed/commentcorrection/17135220-3978515, http://linkedlifedata.com/resource/pubmed/commentcorrection/17135220-8461221, http://linkedlifedata.com/resource/pubmed/commentcorrection/17135220-8820089, http://linkedlifedata.com/resource/pubmed/commentcorrection/17135220-8847282, http://linkedlifedata.com/resource/pubmed/commentcorrection/17135220-9886728
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9602087
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antihypertensive Agents, http://linkedlifedata.com/resource/pubmed/chemical/Sulfonamides, http://linkedlifedata.com/resource/pubmed/chemical/bosentan
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	1468-201X
pubmed:author	pubmed-author:ArgientoPP, pubmed-author:BadagliaccaRR, pubmed-author:CalabròRR, pubmed-author:D'AltoMM, pubmed-author:FedeleFF, pubmed-author:FerranteFF, pubmed-author:ManconeMM, pubmed-author:PosciaRR, pubmed-author:RomeoEE, pubmed-author:RussoM GMG, pubmed-author:SantoriMM, pubmed-author:SarubbiBB, pubmed-author:VizzaC DCD
pubmed:issnType	Electronic
pubmed:volume	93
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	621-5
pubmed:dateRevised	2010-9-15
pubmed:meshHeading	pubmed-meshheading:17135220-Administration, Oral, pubmed-meshheading:17135220-Adult, pubmed-meshheading:17135220-Antihypertensive Agents, pubmed-meshheading:17135220-Dose-Response Relationship, Drug, pubmed-meshheading:17135220-Eisenmenger Complex, pubmed-meshheading:17135220-Exercise Tolerance, pubmed-meshheading:17135220-Female, pubmed-meshheading:17135220-Heart Rate, pubmed-meshheading:17135220-Humans, pubmed-meshheading:17135220-Hypertension, Pulmonary, pubmed-meshheading:17135220-Long-Term Care, pubmed-meshheading:17135220-Male, pubmed-meshheading:17135220-Oxygen Consumption, pubmed-meshheading:17135220-Prospective Studies, pubmed-meshheading:17135220-Sulfonamides, pubmed-meshheading:17135220-Treatment Outcome, pubmed-meshheading:17135220-Vascular Resistance
pubmed:year	2007
pubmed:articleTitle	Long term effects of bosentan treatment in adult patients with pulmonary arterial hypertension related to congenital heart disease (Eisenmenger physiology): safety, tolerability, clinical, and haemodynamic effect.
pubmed:affiliation	Second University of Naples, A O Monaldi, Naples, Italy. mic.dalto@tin.it
pubmed:publicationType	Journal Article